Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the page revision from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe study’s outcome assessment windows and follow-up durations were updated to extend monitoring to up to about 70 months, replacing shorter timeframes. A government funding lapse notice previously shown on the page has been removed.SummaryDifference0.7%

- Check49 days agoChange DetectedResults for the study have been posted on the page, including a 'Results First Posted' date (2025-02-20) and related outcome data added to the study record.SummaryDifference0.3%

- Check63 days agoChange DetectedAdded a new PubMed publication entry (CheckMate 8KX pharmacokinetics/safety study) to the Publications section; no deletions or core-content changes detected.SummaryDifference3%

- Check70 days agoChange DetectedSummary of changes: updated operating status notice and version to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check78 days agoChange Detected- The page now shows a new revision: v3.1.0 in place of v3.0.2. This indicates a release/version update.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.